| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/08/2004 | CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
| 09/08/2004 | CN1165341C Liquid gonadotropin containing formulations |
| 09/08/2004 | CN1165340C Cartilage/bone inducing materials for reparation |
| 09/08/2004 | CN1165339C Pharmaceutical compositions of erythropoietin |
| 09/08/2004 | CN1165338C Endoparasiticidal compositions |
| 09/08/2004 | CN1165336C Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/07/2004 | US6787647 Carnitine carrier related protein-1 |
| 09/07/2004 | US6787645 Platelet derived growth factors; for stimulating and/or enhancing immune responsiveness and in wound healing and related tissue repair; for tumor suppression, cancer treatment |
| 09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
| 09/07/2004 | US6787640 Fibroblast growth factor 14 |
| 09/07/2004 | US6787637 Comprises administering agents that induce beneficial |
| 09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
| 09/07/2004 | US6787523 Alzheimer's disease, administering an a beta peptide and an adjuvant in a regime effective to induce an immune response comprising antibodies to the a beta peptide, the adjuvant enhancing the immune response to the a beta peptide, |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/07/2004 | US6787519 Methods of treating disorders related to apoE |
| 09/07/2004 | US6787518 Therapeutics of osteoarthritis and inflammatory joint disease |
| 09/07/2004 | US6787517 Agent and methods for treating pain |
| 09/07/2004 | US6787352 Nucleotide sequences coding polypeptide fpr use in the human therapeutics, pharmacology, foods and animal feeds |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787336 DNA encoding growth hormone antagonists |
| 09/07/2004 | US6787328 Methods and compositions relating to CD39-like polypeptides and nucleic acids |
| 09/07/2004 | US6787326 For destruction in normoxic but not hypoxic cells; promotes angiogenesis and/or cellular survival; fusion proteins |
| 09/07/2004 | US6787320 In vitro methods for determining in vivo thrombotic events |
| 09/07/2004 | US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 09/07/2004 | US6787317 Method of identifying missing domains in receptors |
| 09/07/2004 | US6787311 Diagnosis of premature ovarian failure |
| 09/07/2004 | US6787158 Process for treatment of a lactic raw material |
| 09/07/2004 | US6787153 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 09/07/2004 | US6787145 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/07/2004 | US6787144 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787143 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787142 Mutant human hepatitis B viral strain and uses thereof |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | US6787140 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787139 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787138 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787137 Campylobacter vaccine |
| 09/07/2004 | US6787136 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/07/2004 | US6787135 For inhibiting proliferative diabetic retinopathy; plasmin induces posterior detachment of the vitreous |
| 09/07/2004 | US6787134 Methods for preventing/remedying mastitis |
| 09/07/2004 | US6787132 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/07/2004 | CA2421321A1 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis |
| 09/07/2004 | CA2173594C Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| 09/07/2004 | CA2093770C Aspartic acid derivatives, their preparation and use |
| 09/02/2004 | WO2004074510A1 Methods of diagnosis and prognosis of pancreatic cancer |
| 09/02/2004 | WO2004074494A1 Method of treating ischemic disease |
| 09/02/2004 | WO2004074486A2 Fusion proteins of interferon alpha muteins with improved properties |
| 09/02/2004 | WO2004074484A1 Method of screening apoptosis-controlling agent |
| 09/02/2004 | WO2004074475A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 09/02/2004 | WO2004074470A1 High protease content pancreatin |
| 09/02/2004 | WO2004074461A2 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | WO2004074454A2 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 09/02/2004 | WO2004074448A2 mTOR KINASE-ASSOCIATED PROTEINS |
| 09/02/2004 | WO2004074446A2 Parkin interacting polypeptides and methods of use |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074433A2 Rag polypeptides, nucleic acids, and their use |
| 09/02/2004 | WO2004074428A2 Treatment of metabolic disorders |
| 09/02/2004 | WO2004074322A1 Modified soluble t cell receptor |
| 09/02/2004 | WO2004074319A1 Physiologically active peptides and drugs containing the same |
| 09/02/2004 | WO2004074318A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 09/02/2004 | WO2004074316A1 Conformationally constrained backbone cyclized peptide analogs |
| 09/02/2004 | WO2004074315A2 Analogues of glp-1 |
| 09/02/2004 | WO2004074312A2 Tryptophyllin peptides and uses thereof |
| 09/02/2004 | WO2004074311A2 Human cyclooxygenase-3 and uses thereof |
| 09/02/2004 | WO2004074235A1 Transdermal penetration enhancers |
| 09/02/2004 | WO2004073742A1 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/02/2004 | WO2004073741A1 Remedy for spinal injury containing interleukin-6 antagonist |
| 09/02/2004 | WO2004073740A1 Regulator of interstitial angiotensin ii hyperproduction and preventive or remedy for the onset of arteriosclerosis, heart and brain vascular diseases and/or diabetic complications |
| 09/02/2004 | WO2004073734A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation |
| 09/02/2004 | WO2004073733A1 Interleukin 6 production inhibitor |
| 09/02/2004 | WO2004073732A1 Modulators of notch signalling and of immune cell costimulatory activity for immunotherapy |
| 09/02/2004 | WO2004073731A1 14-3-3 protein for prevention and treatment of fibroproliferative disorders |
| 09/02/2004 | WO2004073730A1 Anticancer agent comprising lk8 protein as an active ingredient |
| 09/02/2004 | WO2004073728A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 09/02/2004 | WO2004073706A1 Drug for reducing side effects in ribavirin interferon combination therapy |
| 09/02/2004 | WO2004073693A1 Soft capsule containing cyclosporine and it's manufacturing process |
| 09/02/2004 | WO2004073684A2 Lipophilic drug delivery vehicle and methods of use thereof |
| 09/02/2004 | WO2004073677A1 Therapeutic agent angiogen |
| 09/02/2004 | WO2004073652A2 Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination |
| 09/02/2004 | WO2004073651A2 Identifying inhibitors of intracellular protein fibrillization |
| 09/02/2004 | WO2004073650A2 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 09/02/2004 | WO2004073649A2 Clk-peptide and slk-peptide |
| 09/02/2004 | WO2004073648A2 Composition and methods for inhibiting cell survival |
| 09/02/2004 | WO2004073644A2 Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
| 09/02/2004 | WO2004073641A2 Induced activation in dendritic cells |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004073633A2 Methods and compositions for modulating the development of stem cells |
| 09/02/2004 | WO2004073630A2 Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
| 09/02/2004 | WO2004073625A2 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/02/2004 | WO2004073624A2 Contraceptive methods and compositions related to proteasomal interference |
| 09/02/2004 | WO2004073616A2 Elastin digest compositions and methods utilizing same |
| 09/02/2004 | WO2004073614A2 Combination therapy for the treatment of immunoinflammatory disorders |
| 09/02/2004 | WO2004073609A2 Posh associated kinases and related methods |
| 09/02/2004 | WO2004073586A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 09/02/2004 | WO2004073504A2 Methods for the treatment and prevention of diseases of biological conduits |
| 09/02/2004 | WO2004062551A3 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 09/02/2004 | WO2004052773A3 Peptide nanostructures, methods for their preparation and use |
| 09/02/2004 | WO2004052284A3 Treatment of diabetes |
| 09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |